Medicare Formularies Should Ensure Off-Label Rx Coverage – Neurologist
Medicare prescription drug plan formularies need to incorporate a mechanism for coverage of off-label drug use, American Academy of Neurology Representative John Gates, MD, said
You may also be interested in...
U.S. Pharmacopeia's draft model for Medicare prescription drug formularies establishes 146 unique therapeutic categories and pharmacologic classes, falling in between the numbers of drug groups sought by drug manufacturers and PBMs
Pfizer will provide periodic reports to the HHS Inspector General about off-label use trends for its products under the May 13 settlement of an investigation into the company's promotion of Neurontin
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011